| Julia Degler, MD | |
|
300 E Boyd Ave, Suite #120, Greenfield, IN 46140-2834 | |
| (317) 462-3441 | |
| (317) 462-5476 |
| Full Name | Julia Degler |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 300 E Boyd Ave, Greenfield, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295996346 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01067844A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hancock Regional Hospital | Greenfield, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hancock Physician Network, Llc | 8325952633 | 107 |
News Archive
Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer's plant-derived malaria transmission-blocking vaccine (TBV), which targets the Pfs25 antigen, to proceed into the clinic in a Phase 1 safety and immunogenicity study.
A decade-old treatment recommendation for people with cancer to take a "slowly slowly" approach to exercise has been replaced with new guidelines recommending a personalized exercise program including high-intensity workouts to achieve the best treatment outcome.
For the estimated 13 percent of new mothers who experience postpartum depression, counseling and peer support groups appear to offer symptom relief without medication, a new review of research suggests.
The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing's disease patients who cannot be helped through surgery.
› Verified 8 days ago
| Entity Name | Hancock Physician Network, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609806470 PECOS PAC ID: 8325952633 Enrollment ID: O20040130000777 |
News Archive
Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer's plant-derived malaria transmission-blocking vaccine (TBV), which targets the Pfs25 antigen, to proceed into the clinic in a Phase 1 safety and immunogenicity study.
A decade-old treatment recommendation for people with cancer to take a "slowly slowly" approach to exercise has been replaced with new guidelines recommending a personalized exercise program including high-intensity workouts to achieve the best treatment outcome.
For the estimated 13 percent of new mothers who experience postpartum depression, counseling and peer support groups appear to offer symptom relief without medication, a new review of research suggests.
The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing's disease patients who cannot be helped through surgery.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julia Degler, MD 300 E Boyd Ave, Suite #120, Greenfield, IN 46140-2834 Ph: (317) 462-3441 | Julia Degler, MD 300 E Boyd Ave, Suite #120, Greenfield, IN 46140-2834 Ph: (317) 462-3441 |
News Archive
Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announced today that clearance was obtained from the U.S. Food and Drug Administration (FDA) for an investigational new drug (IND), Fraunhofer's plant-derived malaria transmission-blocking vaccine (TBV), which targets the Pfs25 antigen, to proceed into the clinic in a Phase 1 safety and immunogenicity study.
A decade-old treatment recommendation for people with cancer to take a "slowly slowly" approach to exercise has been replaced with new guidelines recommending a personalized exercise program including high-intensity workouts to achieve the best treatment outcome.
For the estimated 13 percent of new mothers who experience postpartum depression, counseling and peer support groups appear to offer symptom relief without medication, a new review of research suggests.
The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection for the treatment of Cushing's disease patients who cannot be helped through surgery.
› Verified 8 days ago
Thomas O'connor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E Boyd Ave, Suite 100, Greenfield, IN 46140 Phone: 317-462-5252 Fax: 317-462-8010 | |
Dr. Ray A Haas, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 W Mckenzie Rd, Suite H, Greenfield, IN 46140 Phone: 317-462-2335 Fax: 317-462-2069 | |
Bernard Richard, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 740 W Green Meadows Dr, Suite 105, Greenfield, IN 46140 Phone: 317-318-7777 Fax: 317-318-7700 | |
Dr. Mark E Lemmons, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1515 N State St, Greenfield, IN 46140 Phone: 317-467-4300 Fax: 317-467-4302 | |
Stephanie J Kinnaman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E Boyd Ave, Suite 100, Greenfield, IN 46140 Phone: 317-462-5252 Fax: 317-462-8010 | |
Amy R. Wooldridge, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Sq Ste 305, Greenfield, IN 46140 Phone: 317-462-6662 Fax: 317-468-6275 |